Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Non-Current Assets (2016 - 2026)

Dexcom has reported Non-Current Assets over the past 17 years, most recently at $2.3 billion for Q1 2026.

  • Quarterly Non-Current Assets rose 4.72% to $2.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.2 billion through Mar 2026, up 9.06% year-over-year, with the annual reading at $2.3 billion for FY2025, 5.66% up from the prior year.
  • Non-Current Assets was $2.3 billion for Q1 2026 at Dexcom, roughly flat from $2.3 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.3 billion in Q4 2025 and troughed at $1.3 billion in Q1 2022.
  • The 5-year median for Non-Current Assets is $1.9 billion (2023), against an average of $1.9 billion.
  • Year-over-year, Non-Current Assets surged 38.71% in 2022 and then increased 4.72% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $1.7 billion in 2022, then rose by 6.72% to $1.8 billion in 2023, then increased by 18.74% to $2.2 billion in 2024, then grew by 5.66% to $2.3 billion in 2025, then dropped by 0.22% to $2.3 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Non-Current Assets are $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025).